Synapse

← Journal of Market Access & Health Policy

Papers in Journal of Market Access & Health Policy

Page 1 · newest first

  1. Per-Patient Medical Costs of Hemodialysis and Peritoneal Dialysis in JapanJournal of Market Access & Health Policy · 2026
  2. Target Population Estimation in German Orphan Drug HTA: Trends and Differences in Epidemiological Data SourcesJournal of Market Access & Health Policy · 2026
  3. Operational Insights into Hospital Drug Inventory Control Through an Integrated ABC-VEN and Minimum–Maximum Stock Level ApproachJournal of Market Access & Health Policy · 2026
  4. Dialysis-Related Medical Expenditures of Hemodialysis and Peritoneal Dialysis in JapanJournal of Market Access & Health Policy · 2026
  5. Dynamic Medicine Prices for Health-Economic Analyses in the Netherlands: A Case for Integrating Pre- and Post-Exclusivity Price DynamicsJournal of Market Access & Health Policy · 2026
  6. Evaluation of Market Access of Pembrolizumab: A Comparative Study Between Portugal, Spain and the United KingdomJournal of Market Access & Health Policy · 2026
  7. One Europe, Many Patients: A Call to Action to Make EU HTAR More Inclusive in PracticeJournal of Market Access & Health Policy · 2026
  8. Evaluating Locally Grounded Generative AI for Health-Policy Support: A Multilevel Mixed-Methods Pilot StudyJournal of Market Access & Health Policy · 2026
  9. Improving Patient Access to New Treatment Modalities in European Cancer CareJournal of Market Access & Health Policy · 2026
  10. Toward Value-Based Reimbursement for Hemophilia A in the UAE: A Multi-Stakeholder PerspectiveJournal of Market Access & Health Policy · 2026
  11. The Post-Authorisation Maze: Mapping of European Pharmaceutical Market Access Pathways in the Early JCA EraJournal of Market Access & Health Policy · 2026
  12. Real-World Shelf Life of Epinephrine Auto-Injectors in Canada: Implications for Renewal Frequency and Patient BurdenJournal of Market Access & Health Policy · 2026
  13. Analysis of Factors Influencing Drug Prices Differently in Official Drug Pricing and Cost-Effectiveness EvaluationJournal of Market Access & Health Policy · 2026
  14. A Model-Based Public-Payer Investment Appraisal of a National Home Hemodialysis Program in Greece: A Net Present Value AnalysisJournal of Market Access & Health Policy · 2026
  15. From Joint Clinical Assessment to National Decisions: EU HTA Implementation and Implications for Patient AccessJournal of Market Access & Health Policy · 2026
  16. Treatment Preferences in Acute Allergic Reactions—How Can the Context Impact the Preference for a Corticosteroid Mouth Film Versus Conventional Tablets?Journal of Market Access & Health Policy · 2026
  17. Health-Related Quality of Life of Patients with Epidermolysis bullosa and Carers Using a Time Trade-Off Approach in the UK General Population to Elicit Utilities for Health Technology AssessmentJournal of Market Access & Health Policy · 2026
  18. Guidance on Multiplicity Analysis in Single-Trial Assessments: A No-Solution EquationJournal of Market Access & Health Policy · 2026
  19. Valuation of Medical Innovation in Orphan Diseases with a Focus on Small Investors and Limited Diversifiable RisksJournal of Market Access & Health Policy · 2026
  20. Direct Public-Payer Costs of Dialysis Therapies in Greece: A Patient-Level Micro-Costing Study Across Modality and Provider SectorJournal of Market Access & Health Policy · 2026
  21. A Real-World Clinical Trial Evaluating Satisfaction and Experiences with a Dexamethasone Mouth Film Compared to Corticosteroid Tablets as Rescue Medication for Moderate to Severe Acute Allergic ReactionsJournal of Market Access & Health Policy · 2026
  22. Multi-Criteria Decision-Making Framework for Sustainable Innovation Management in the Mexican Medical Device Manufacturing Industry: An Exploratory and Interdisciplinary AnalysisJournal of Market Access & Health Policy · 2026
  23. Analysis of How the Term “Shall” Is Understood and Applied to the EU-HTA RegulationJournal of Market Access & Health Policy · 2026
  24. Market Care and Custody: A Health Policy Analysis of Incarceration and Long-Term Care Systems in the U.S.Journal of Market Access & Health Policy · 2026
  25. The Analytical Framework of Clinical Trials Evaluating Clinical Outcomes of Artificial Intelligence-Based Digital Health Interventions: A Systematic Literature ReviewJournal of Market Access & Health Policy · 2026
  26. Supporting the Implementation and Addressing the Challenges of the EU HTA RegulationJournal of Market Access & Health Policy · 2026
  27. Operative Costs and Anesthesia Exposure Time for Pediatric Glaucoma SurgeriesJournal of Market Access & Health Policy · 2026
  28. A Decision Tree Cost Analysis of Intracranial Bleed Detection Using a Near-Infrared Device Across Various Healthcare LevelsJournal of Market Access & Health Policy · 2026
  29. Use of Real-World Evidence in Health Technology Assessments of Non-Oncology Rare Disease TherapiesJournal of Market Access & Health Policy · 2026
  30. EU-HTA—Why Do Words Matter?Journal of Market Access & Health Policy · 2026
  31. Impact of a Digital Leakage Notification System on Healthcare Resource Utilisation and Costs for People with Stomas in the United Kingdom: Analysis of Interim Results from a Prospective Longitudinal StudyJournal of Market Access & Health Policy · 2026
  32. Real-World Shelf Life of Adrenaline Auto-Injectors at Pharmacies in Denmark, Finland, Sweden, and NorwayJournal of Market Access & Health Policy · 2026
  33. Primary Care or Primary Problem? Aligning Access Pathways with Patient Needs Across the Care ContinuumJournal of Market Access & Health Policy · 2026
  34. Assessment and Appraisal of Drug Innovativeness in Italy: Ultimate Evidence on Key Drivers and ConsistencyJournal of Market Access & Health Policy · 2026
  35. Impact of Market Access Delays on Time to Patient Access: Multi-Country Comparative Analysis Assessing the First Commercial Launch Indications for Five Oncology Medicines Across Europe and CanadaJournal of Market Access & Health Policy · 2026
  36. Introducing an Expanded Value Framework in Health Technology Assessment of VaccinesJournal of Market Access & Health Policy · 2026
  37. When Do Annuity-Based Payments Help to Address the Affordability Challenge of Funding Advanced Therapies? Insights from a Budget Impact SimulationJournal of Market Access & Health Policy · 2026
  38. Household Out-of-Pocket Burden Costs for Pediatric Pneumonia in Low- and Middle-Income Countries: Evidence Review and Econometric FrameworkJournal of Market Access & Health Policy · 2026
  39. Accessibility of Biologic Drugs in Morocco: Comparison with FDA and EMA Approvals (2015–2025)Journal of Market Access & Health Policy · 2026
  40. Cost-Effectiveness of 3D-Printed Patient-Specific Versus Off-the-Shelf Interbody Cages in Lumbar Spinal Fusion: A Markov Model Cost-Utility AnalysisJournal of Market Access & Health Policy · 2026
  41. Mapping the Use of Real-World Evidence Across the EU Health Technology Assessment Regulation: Methodological Considerations, Challenges, and Opportunities for HarmonizationJournal of Market Access & Health Policy · 2026
  42. When Activism Becomes Survival: The Mental Health Costs of Constant Resistance in the Digital Era in the Balkans—A Health Policy PerspectiveJournal of Market Access & Health Policy · 2026
  43. Comparative Cost Evaluation of Managed Entry Agreement Techniques Using Real-World Data from High-Cost Anticancer Drugs in ThailandJournal of Market Access & Health Policy · 2026
  44. Validation of a De Novo Health Economic Model for Finerenone in Heart Failure with Left Ventricular Ejection Fraction ≥40%Journal of Market Access & Health Policy · 2026
  45. Addressing Unmet Medical Needs in Drug Development: Assessment and Implications for Regulatory and Clinical Development StrategiesJournal of Market Access & Health Policy · 2026
  46. Can We Trust PAICs in Rare Diseases? Methodological Challenges and LimitationsJournal of Market Access & Health Policy · 2026
  47. A Cost-Effectiveness Analysis of the Sentio Bone Conduction Hearing Implant System in the Australian Healthcare SettingJournal of Market Access & Health Policy · 2026
  48. Updated Conversion Table for the Multiple Criteria Qualitative Value-Based Pricing Framework “MARIE”Journal of Market Access & Health Policy · 2026
  49. Structural Enablers of Rare Disease Treatment Coverage in Latin America and the Caribbean: Lessons from EmicizumabJournal of Market Access & Health Policy · 2026
  50. Optimising Investment in Health Innovations in EuropeJournal of Market Access & Health Policy · 2026